TABLE 2.

Neuropsychological scores (median value) from baseline to follow-up and “Median (Q1, Q3),” “H-statistic,” and “P-value”.

Tests	Meditation group (N = 13)	Non-meditation-focused task group (N = 9)	Treatment-as-usual (TAU) group (N = 10)	Kruskal–wallis test
	Median baseline score → median follow-up score: median SPC (Q1, Q3)			H- Statistic (P-value)
CDR-Sum of Boxes	2 → 2 −4.101 (−5.917, 6.452)	2.5 → 2 0.00 (−5.825, 3.106)	1.75 → 2.25 0.00 (−5.561, 8.782)	0.166 (0.920)
MOCA	18.5 → 17 −0.677 (−2.277, 0.606)	18 → 18 1.713 (0.5, 2.708)	18 → 21 0.000 (−1.839, 1.009)	3.218 (0.200)
Digit span forward task	5 → 6 0.00 (0.00, 3.190)	4 → 5 0.00 (0.00, 2.347)	5 → 4 −2.946 (−5.97, 0.00)	5.757 (0.056)
Digit span backward task	3 → 4 0.00 (0.00, 0.00)	4 → 4 0.00 (0.00, 0.00)	3.5 → 4 0.00 (0.00, 1.374)	0.244 (0.885)
TMT-A	88 → 99 0.375 (−1.893, 4.593)	115 → 103 −1.348 (−4.69, 0.245)	93 → 100.5 0.233 (−0.127, 1.353)	2.750 (0.253)
TMT-B	300 → 290 0.00 (−0.334, 0.00)	300 → 300 0.00 (0.00, 0.355)	286.5 → 300 0.00 (0.00, 0.914)	0.262 (0.877)
TMT-(B-A)	171 → 148 −0.999 (−3.687, 0.410)	154 → 183 3.820 (−0.857, 4.698)	154 → 121 0.00 (−3.189, 1.423)	3.795 (0.150)
CERAD IR	16 → 19 0.592 (−1.21, 1.77)	19 → 18 1.056 (−0.92, 2.61)	15 → 17.5 2.663 (0.38, 3.61)	2.883 (0.237)
CERAD DR	3 → 4 3.128 (0.00, 5.69)	1 → 3 0.000 (−20.61, 14.56)	4 → 3.5 0.485 (−2.98, 4.00)	0.474 (0.789)
CERAD RECOG	16 → 18 1.109 (0.00, 2.769)	15 → 17 0.000 (−0.925, 2.721)	16.5 → 18 1.674 (−0.317, 3.718)	1.366 (0.505)

MOCA, Montreal Cognitive Assessment; TMT, Trail Making Task; CERAD, Consortium to Establish a Registry for Alzheimer’s Disease; CERAD (IR), (DR), (RECOG), Immediate Recall, Delayed Recall, Recognition.